|
Amid global panic about a possible mutation of bird flu, another Korean pharmaceutical firm said Tuesday it succeeded in making a generic version of the only available influenza drug Tamiflu. Ilyang Pharm. said Tuesday it submitted the trial product and related documents to the Korean Food and Drug Administration (KFDA), a day after Hanmi Pharmaceutical did the same.
The government is considering a temporary suspension of the Swiss pharmaceutical giant Roche¡¯s patent on the drug to enable domestic firms to produce it in case a pandemic of human-to-human transmissible avian flu strikes the country. Roche is instead promoting joint production with Korean companies. The KFDA has handed Roche a list of 15 Korean pharma companies willing to make the drug jointly with the Swiss firm.
(englishnews@chosun.com )
|
